Tag Archives: BIO CEO

Session Recap: Advances in Ophthalmology: Therapies for Saving Sight

ophthalmology panel at BIO CEO & Investor Conference

Monday at the BIO CEO & Investor Conference featured a 9:30am panel that offered a comprehensive perspective on what is happening in the world of ophthalmology today.  The panel was moderated by Tony Gibney, Managing Director, Leerink Partners. The panelists were: Jeffrey L. Cleland, PhD, Interim Chief Executive Officer, GrayBug Guy Eakins, PhD, Vice President, Scientific Affairs, BrightFocus Foundation Nouhad Husseini, Vice President, Business Development, Regeneron David P. Southwell, President and Chief Executive Officer, Inotek Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Announcing the BIO/Bloomberg Intelligence: 2016 Biotech Industry Outlook Survey

BIO CEO and Investor Conference

BIO, in conjunction with Bloomberg Intelligence, invites you to answer a brief, 3-minute, industry outlook survey. Please share your expertise to tap into the “wisdom of the crowd.” Answer our 16 questions to get your 2016 answers. Survey participants will get first access to results before the rest of the biotech community. All responses will remain anonymous. Where do your forecasts fit among your colleagues’ estimates? What research developments are they watching most closely? Click Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO CEO & Investor Conference Closes with Record Breaking Partnering Numbers

bio-ceo-blog

The 17th Annual BIO CEO & Investor Conference, the largest investor conference focused on established and emerging publicly traded and select private biotech companies, took place last week in New York City at the Waldorf Astoria with more than 1,400 registrants, including 620 registered investors. The event featured 9 educational program sessions, including business roundtables, therapeutic workshops and plenary sessions, 5 fireside chats with biotech and pharma CEOs as well as nearly 170 company presentations. Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Nasdaq Social Bell: Twitter Strategies For Biotechs

Nasdaq Social Bell

Last week at the BIO CEO & Investor Conference in New York City, I had the pleasure of speaking with John Machiz and Brad Smith from Nasdaq at their headquarters in Times Square to discuss the social media activity that happened onsite during the event, what made the discussion of the event online so robust, and what biotech companies can do to increase their visibility on Twitter. View the video below, and get a recap of the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Session Recap: “Trust Your Gut” – Therapeutic Opportunities from the Microbiome

Kaylee_dna_115x76

Tuesday at the BIO CEO & Investor Conference kicked off with a Therapeutic Workshop titled, “Trust Your Gut” – Therapeutic Opportunities from the Microbiome. The panel was moderated by Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co. The panelists were: Martin J. Blaser, MD, Muriel and George Singer Professor of Medicine, Professor of Microbiology, Director, Human Microbiome Program, New York University Langone Medical Center Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome Michael Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,